Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Perrigo Head Tightens Reins On Consumer Healthcare Sales, Marketing

This article was originally published in The Tan Sheet

Executive Summary

Perrigo has moved its Consumer Healthcare head to direct global operations for OTC and Rx products while President and CEO Joseph Papa will have the firm's consumer products sales and marketing staff report directly to him

You may also be interested in...



CHPA board elections

The Consumer Healthcare Products Association announces March 15 Richard H. June, vice president of Global Personal Health for Procter & Gamble was elected CHPA chair-elect at the trade group's annual executive conference. June will take the association's lead role in 2008. He currently serves as chair of the Finance Committee. June will serve as chair-elect under the re-elected current CHPA Chair John T. Hendrickson, executive vice president and general manager of Perrigo Consumer Healthcare...

Perrigo Foresees 2008 Omeprazole Launch; New Products Offset Sales Woes

Perrigo expects to be able to launch the first store-brand equivalent to Prilosec OTC in November 2008, at the expiration of a 30-month stay

Warnings Note Disease Treatment Studies Placed Too Close To Supplements For US FDA’s Comfort

Dietary ingredients identified in recent FDA warning letters as linked to disease claims by marketers directing customers to scientific literature include omega-3 fatty acid, ginkgo biloba, glucosamine curcumin and vitamin D.

Topics

UsernamePublicRestriction

Register

RS150923

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel